NASDAQ:BIOC - Biocept News Headlines

Sign in or create an account to add this stock to your watchlist.
$6.23 -0.25 (-3.86 %)
(As of 07/20/2018 02:07 PM ET)
Previous Close$6.23
Today's Range$6.15 - $6.40
52-Week Range$3.50 - $44.55
Volume7,835 shs
Average Volume1.24 million shs
Market Capitalization$14.31 million
P/E Ratio-0.27
Dividend YieldN/A
Beta1.89

Headlines

Biocept (NASDAQ BIOC) News Headlines

Source:
DateHeadline
Biocept Reminds Investors of Todays Deadline to be a Shareholder of RecordBiocept Reminds Investors of Today's Deadline to be a Shareholder of Record
finance.yahoo.com - July 19 at 4:47 PM
Biocept, Inc. (BIOC) Soars: Stock Adds 9.8% in SessionBiocept, Inc. (BIOC) Soars: Stock Adds 9.8% in Session
finance.yahoo.com - July 16 at 4:50 PM
Todays Research Reports on Stocks to Watch: Biocept and Johnson and JohnsonToday's Research Reports on Stocks to Watch: Biocept and Johnson and Johnson
finance.yahoo.com - July 16 at 4:50 PM
Mid-Afternoon Market Update: Crude Oil Up Over 1%; Biocept Shares Surge On Marketing Agreement For Proprietary Liquid Biopsy TestsMid-Afternoon Market Update: Crude Oil Up Over 1%; Biocept Shares Surge On Marketing Agreement For Proprietary Liquid Biopsy Tests
www.benzinga.com - July 15 at 9:54 AM
Biocept announces marketing and distribution agreement with Alliance Global FZBiocept announces marketing and distribution agreement with Alliance Global FZ
seekingalpha.com - July 15 at 9:54 AM
Biocept (BIOC) Enters Pact with Alliance Global FZ to Market and Distribute Liquid Biopsy Testing in MEAA (Earlier)Biocept (BIOC) Enters Pact with Alliance Global FZ to Market and Distribute Liquid Biopsy Testing in MEAA (Earlier)
www.streetinsider.com - July 15 at 9:54 AM
Biocept Rallies On Marketing Agreement For Proprietary Liquid Biopsy TestsBiocept Rallies On Marketing Agreement For Proprietary Liquid Biopsy Tests
www.benzinga.com - July 15 at 9:54 AM
BIOC: What’s Going on With Biocept Stock?BIOC: What’s Going on With Biocept Stock?
investorplace.com - July 15 at 9:54 AM
Why RH, Biocept, and Lowes Jumped TodayWhy RH, Biocept, and Lowe's Jumped Today
www.fool.com - July 14 at 3:36 PM
US STOCKS ON THE MOVE-Wells Fargo, Citi, AT&T, RH, Biocept, AurisUS STOCKS ON THE MOVE-Wells Fargo, Citi, AT&T, RH, Biocept, Auris
www.nasdaq.com - July 14 at 3:36 PM
Mid-Afternoon Market Update: Crude Oil Up Over 1%; Biocept Shares Surge On Marketing Agreement For Proprietary ...Mid-Afternoon Market Update: Crude Oil Up Over 1%; Biocept Shares Surge On Marketing Agreement For Proprietary ...
www.nasdaq.com - July 14 at 3:36 PM
Why Biocept, Inc. Is Rebounding Big-Time TodayWhy Biocept, Inc. Is Rebounding Big-Time Today
www.fool.com - July 14 at 3:36 PM
Why RH, Biocept, and Lowe's Jumped TodayWhy RH, Biocept, and Lowe's Jumped Today
finance.yahoo.com - July 14 at 3:36 PM
BIOC: What’s Going on With Biocept Stock?BIOC: What’s Going on With Biocept Stock?
investorplace.com - July 14 at 2:47 PM
EOLS Makes Investors Smile, ACIU Up 72% In 4 Days, Busy Days Ahead For ABUSEOLS Makes Investors Smile, ACIU Up 72% In 4 Days, Busy Days Ahead For ABUS
www.nasdaq.com - July 12 at 8:14 AM
Todays Research Reports on Trending Tickers: Biocept and Myriad GeneticsToday's Research Reports on Trending Tickers: Biocept and Myriad Genetics
finance.yahoo.com - July 12 at 8:14 AM
Biocept tries to break downtrend, up 27%Biocept tries to break downtrend, up 27%
seekingalpha.com - July 11 at 5:00 PM
Biocept Highlights Recent Progress and Outlines Near-Term Strategic Priorities in CEO Letter to StockholdersBiocept Highlights Recent Progress and Outlines Near-Term Strategic Priorities in CEO Letter to Stockholders
finance.yahoo.com - June 25 at 8:29 AM
Published Case Report Demonstrates the Clinical Utility of Biocepts CTC Platform in the Management of Patients with ...Published Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with ...
www.prnewswire.com - June 20 at 8:36 AM
Free Stock Performance Review on Agilent Technologies and Three Additional Medical Research StocksFree Stock Performance Review on Agilent Technologies and Three Additional Medical Research Stocks
finance.yahoo.com - June 20 at 8:36 AM
Published Case Report Demonstrates the Clinical Utility of Biocepts CTC Platform in the Management of Patients with Metastatic Breast CancerPublished Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with Metastatic Breast Cancer
finance.yahoo.com - June 18 at 8:39 AM
VWR, Part of Avantor, and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCsVWR, Part of Avantor, and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCs
finance.yahoo.com - June 11 at 8:11 AM
Biocepts (BIOC) CEO Michael Nall on Q1 2018 Results - Earnings Call TranscriptBiocept's (BIOC) CEO Michael Nall on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - June 9 at 5:21 PM
Head to Head Comparison: Biocept (BIOC) and Cancer Genetics (CGIX)Head to Head Comparison: Biocept (BIOC) and Cancer Genetics (CGIX)
www.americanbankingnews.com - June 6 at 5:32 AM
Head-To-Head Comparison: Biocept (BIOC) and Fulgent Genetics (FLGT)Head-To-Head Comparison: Biocept (BIOC) and Fulgent Genetics (FLGT)
www.americanbankingnews.com - June 5 at 10:33 AM
Biocept to Present at the 8th Annual LD Micro Invitational Conference on June 5Biocept to Present at the 8th Annual LD Micro Invitational Conference on June 5
finance.yahoo.com - May 29 at 8:20 AM
WestPark Capital Downgrades Biocept (BIOC) to NeutralWestPark Capital Downgrades Biocept (BIOC) to Neutral
www.streetinsider.com - May 24 at 8:14 AM
Biocept (BIOC) Downgraded by Westpark CapitalBiocept (BIOC) Downgraded by Westpark Capital
www.americanbankingnews.com - May 23 at 3:09 PM
Biocept (BIOC) Stock Rating Upgraded by Zacks Investment ResearchBiocept (BIOC) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - May 16 at 6:37 PM
Biocept (BIOC) Releases  Earnings Results, Misses Expectations By $0.03 EPSBiocept (BIOC) Releases Earnings Results, Misses Expectations By $0.03 EPS
www.americanbankingnews.com - May 16 at 10:35 AM
Biocept Reports First Quarter 2018 Financial ResultsBiocept Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 15 at 5:53 PM
Biocept (BIOC) vs. Cancer Genetics (CGIX) Financial ContrastBiocept (BIOC) vs. Cancer Genetics (CGIX) Financial Contrast
www.americanbankingnews.com - May 12 at 5:17 AM
Biocept (BIOC) Rating Lowered to Hold at Zacks Investment ResearchBiocept (BIOC) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - May 11 at 6:49 PM
Biocept to Release First Quarter 2018 Financial Results and Host Investor Conference Call on May 15, 2018Biocept to Release First Quarter 2018 Financial Results and Host Investor Conference Call on May 15, 2018
finance.yahoo.com - May 8 at 8:10 AM
Head to Head Review: Quest Diagnostics (DGX) vs. Biocept (BIOC)Head to Head Review: Quest Diagnostics (DGX) vs. Biocept (BIOC)
www.americanbankingnews.com - May 5 at 7:25 PM
Biocept (BIOC) Stock Rating Upgraded by ValuEngineBiocept (BIOC) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - May 3 at 10:32 PM
Biocept (BIOC) Scheduled to Post Quarterly Earnings on WednesdayBiocept (BIOC) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - May 2 at 3:50 AM
Head to Head Comparison: Biocept (BIOC) & Its RivalsHead to Head Comparison: Biocept (BIOC) & Its Rivals
www.americanbankingnews.com - May 2 at 1:08 AM
Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocepts Liquid Biopsy Test for ...Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ...
www.prnewswire.com - May 1 at 8:17 AM
Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocepts Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung CancerCase Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer
finance.yahoo.com - May 1 at 8:16 AM
Published Case Study Demonstrates the Clinical Utility of Biocepts Liquid Biopsy Test for ALK RearrangementsPublished Case Study Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ALK Rearrangements
finance.yahoo.com - April 27 at 8:25 AM
Reviewing Biocept (BIOC) and Its RivalsReviewing Biocept (BIOC) and Its Rivals
www.americanbankingnews.com - April 23 at 5:04 PM
Critical Survey: Biocept (BIOC) and Genomic Health (GHDX)Critical Survey: Biocept (BIOC) and Genomic Health (GHDX)
www.americanbankingnews.com - April 21 at 7:36 PM
Biocept (BIOC) and Its Competitors Critical AnalysisBiocept (BIOC) and Its Competitors Critical Analysis
www.americanbankingnews.com - April 21 at 9:18 AM
Reviewing Biocept (BIOC) and Its CompetitorsReviewing Biocept (BIOC) and Its Competitors
www.americanbankingnews.com - April 21 at 9:18 AM
Biocept (BIOC) Downgraded by Zacks Investment ResearchBiocept (BIOC) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 18 at 7:30 PM
Biocept (BIOC) Upgraded by Zacks Investment Research to "Buy"Biocept (BIOC) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 17 at 7:34 PM
Critical Comparison: Biocept (BIOC) versus The CompetitionCritical Comparison: Biocept (BIOC) versus The Competition
www.americanbankingnews.com - April 15 at 5:15 PM
Miragen Therapeutics (MGEN) and Biocept (BIOC) Head to Head SurveyMiragen Therapeutics (MGEN) and Biocept (BIOC) Head to Head Survey
www.americanbankingnews.com - April 12 at 11:19 PM
Westpark Capital Reaffirms Outperform Rating for Biocept (BIOC)Westpark Capital Reaffirms Outperform Rating for Biocept (BIOC)
www.americanbankingnews.com - April 12 at 9:35 PM
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.